Carl Zeiss Meditec Balance Sheet Health
Financial Health criteria checks 5/6
Carl Zeiss Meditec has a total shareholder equity of €2.1B and total debt of €142.0M, which brings its debt-to-equity ratio to 6.7%. Its total assets and total liabilities are €2.9B and €812.9M respectively. Carl Zeiss Meditec's EBIT is €271.3M making its interest coverage ratio -36.9. It has cash and short-term investments of €15.3M.
Key information
6.7%
Debt to equity ratio
€142.01m
Debt
| Interest coverage ratio | -36.9x |
| Cash | €15.34m |
| Equity | €2.11b |
| Total liabilities | €812.92m |
| Total assets | €2.92b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AFX's short term assets (€1.8B) exceed its short term liabilities (€507.4M).
Long Term Liabilities: AFX's short term assets (€1.8B) exceed its long term liabilities (€305.5M).
Debt to Equity History and Analysis
Debt Level: AFX's net debt to equity ratio (6%) is considered satisfactory.
Reducing Debt: AFX's debt to equity ratio has increased from 4.5% to 6.7% over the past 5 years.
Debt Coverage: AFX's debt is well covered by operating cash flow (185.4%).
Interest Coverage: AFX earns more interest than it pays, so coverage of interest payments is not a concern.